Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

John Field

Clinical Professor of Molecular Oncology

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Epidemiology Epidemiology professors in United Kingdom

About

John K. Field is a Clinical Professor of Molecular Oncology at [Institution Name], located in the United Kingdom. His research primarily focuses on lung cancer, with recent articles exploring biomarkers for risk stratification, the benefits of low-dose CT screening, and the integration of artificial intelligence in public health settings. He is actively involved in international collaborations aimed at improving lung cancer screening practices and understanding genetic factors associated with the disease.

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (30)

Kjell Grankvist

Full Professor/Senior Consultant

Umeå Universitet

SWEDEN

John Field

Research Interests

Explore related searches

About

Articles (30)

Genome-wide association study for lung cancer in 6531 African Americans reveals new susceptibility loci

External Validation of Plasma Glycosaminoglycans as Biomarkers to Improve Lung Cancer Risk Stratification

External Validation of Plasma Glycosaminoglycans as Biomarkers to Improve Lung Cancer Risk Stratification.

Current evidence of low-dose CT screening benefit

Lung Cancer Screening Program Quality Indicators-Review and Recommendations: An International Association for the Study of Lung Cancer Delphi Process Study.

AI integrations with lung cancer screening: Considerations in developing AI in a public health setting.

Action plan for an international imaging framework for implementation of global low-dose CT screening for lung cancer.

Histological proven AI performance in the UKLS CT lung cancer screening study: Potential for workload reduction

Abstract 3815: High-penetrance rare variants underlying familial lung cancer risk: Insights from the Genetic Epidemiology of Lung Cancer Consortium

190P: Real-world 5-year survival outcomes with durvalumab (D) after chemoradiotherapy (CRT) in unresectable, stage III NSCLC (urNSCLC): Final data extraction from PACIFIC-R

Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies

Occupational Benzene Exposure and Lung Cancer Risk: A Pooled Analysis of 14 Case-Control Studies

Novel Transcriptional and DNA Methylation Abnormalities of SORT1 Gene in Non-Small Cell Lung Cancer

Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R

Impact of single round of low dose CT lung cancer screening on cause of mortality in different socio-economic groups: a post-hoc analysis of long-term follow-up of the UKLS trial

Respirable crystalline silica and lung cancer in community-based studies: impact of job-exposure matrix specifications on exposure-response relationships.

Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.

CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility.

Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification.

Lung Cancer Risks Associated with Occupational Exposure to Pairs of Five Lung Carcinogens: Results from a Pooled Analysis of Case-Control Studies (SYNERGY).

Defining the road map to a UK national lung cancer screening programme

Plasma protein biomarkers for early prediction of lung cancer

Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

Occupational exposure to nickel and hexavalent chromium and the risk of lung cancer in a pooled analysis of case-control studies (SYNERGY)

Attitudes towards the integration of smoking cessation into lung cancer screening in the United Kingdom: A qualitative study of individuals eligible to attend

Selection of eligible participants for screening for lung cancer using primary care data

Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors

Understanding the lung cancer mortality reductions produced by low-dose CT screening—Authors’ reply

A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians

Accounting for EGFR Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data

Collaborators (30)

Kjell Grankvist

Daniel C. Christoph

Florence Menegaux

Andrea Riccardo Filippi

Harry de Koning

Ang Li

Christopher I. Amos

David R Baldwin

Pilar Garrido López

Vilde Drageset Haakensen

Beata Swiatkowska

Karina Dalsgaard Sørensen

Francesco Gatto

Samantha Quaife

Roel Vermeulen

Triantafillos Liloglou

Stig E. Bojesen

Emmanouil Bouras

Sabine Schmid

Ruth Travis

Ryan Sun

Kevin ten Haaf

Pascal Guenel

Matthijs Oudkerk

Catherine Zhu

Sam Janes

Benjamin Kendzia

Jinyoung Byun

Brenda Diergaarde

Carlijn van der Aalst

Make your next move.